29 May 2019 ORYZON announces First Patient in the US in ETHERAL-US: a Phase IIa clinical trial with vafidemstat in Alzheimer’s Disease
25 April 2019 ORYZON to present vafidemstat efficacy data at the 7th World Congress on ADHD in Lisbon
15 April 2019 ORYZON to present further REIMAGINE efficacy data with vafidemstat at the 7th World Congress on ADHD in Lisbon
8 April 2019 ORYZON to present first in human efficacy data with Vafidemstat at the 27th European Congress of Psychiatry in Warsaw
20 March 2019 Oryzon to present latest advances of Vafidemstat at Oppenheimer’s 29th Annual Healthcare Conference